Not yet investigated
What we have so far
A GLP-1 analogue engineered to survive DPP-4 and bind albumin, which is the whole reason a gut hormone with a two-minute half-life became a weekly injection.
This star is on the map because the show intends to take the question apart properly — the trials, how it is actually tested, whether the thing sold is the thing studied. That work is not done yet, and nothing here should be read as a conclusion. When the investigation is published it will appear on this page.